$Pacira BioSciences (PCRX.US)$Revenue has continued to grow ...

逍遥投资派 commented on a stock · May 27, 2023 00:25

$Pacira BioSciences (PCRX.US)$Revenue has continued to grow over the past 5 years, with an average growth rate of 18.4%, operating profit with an average growth rate of 63% in the past 3 years, and an average growth rate of 25.7% in the past 3 years. Net profit has shrunk sharply for 2 consecutive years after reversing losses and reaching a high point in 2020. 2020 was mainly affected by income tax rebates.

2023Q1 revenue increased 1.5%, operating profit fell sharply by 58.5%, and net profit entered the loss range.

Currently, the price-earnings ratio is 117. Even with a net profit high of 42 million in 2021, the price-earnings ratio reached 43, which is unattractive.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

7989 Views

Comment

逍遥投资派

578

Followers

Following

3180

Visitors